<DOC>
	<DOCNO>NCT02111018</DOCNO>
	<brief_summary>Prospective , randomized non-blinded , control study ass feasibility CytoSorb adjunct standard care patient rhabdomyolysis require renal replacement therapy .</brief_summary>
	<brief_title>Extracorporeal Therapy Removal Myoglobin Using CytoSorb Patients With Rhabdomyolysis</brief_title>
	<detailed_description />
	<mesh_term>Rhabdomyolysis</mesh_term>
	<criteria>Subject age 1880 Subjects present rhabdomyolysis Subject require renal replacement therapy undergone adequate volume resuscitation Subject willing comply specify follow requirement Subject legal guardian either decline give inform consent Subject pregnant Subject previously enrol clinical study Comorbid condition may limit survival â‰¤14 day Comorbid condition could confound study result Subjects receive immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>